Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants

NCT00544895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2011-06-23

No results posted yet for this study

Summary

NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)

Conditions

  • Brain Damage, Chronic

Sponsors & Collaborators

Principal Investigators

  • Olaf Dammann · Medical School Hannover

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Completion
2010-10-31

Countries

  • Austria
  • France
  • Germany
  • Italy
  • Netherlands
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00544895 on ClinicalTrials.gov